Back

Reproducibility of Apparent Diffusion Coefficient and Restriction Spectrum Imaging Restriction Score in the Prostate Across MRI Sessions, Vendors, and Acquisition Settings: a Prospective Study

song, y.; Conlin, C. C.; Lee, K.-L.; Dornisch, A.; Barrett, T.; Do, S.; Do, D. D.; Margolis, D. J.; Rakow-Penner, R.; Dale, A.; Liss, M. A.; Seibert, T. M.

2026-05-13 radiology and imaging
10.64898/2026.05.10.26352843 medRxiv
Show abstract

BackgroundDiffusion-weighted MRI is central to prostate cancer detection, but apparent diffusion coefficient (ADC) has limited reproducibility across scanners and sites. Restriction Spectrum Imaging restriction score maximum value (RSIrs-max) may provide a more reproducible biomarker. PurposeTo evaluate cross-session reproducibility of within-lesion mean ADC and RSIrs-max on prostate MRI, including same-vendor and cross-vendor comparisons, and in unfavorable-histology prostate cancer (uhPC) and different interpolation settings. Materials and MethodsIn this prospective study, participants with suspected or known prostate cancer enrolled from August 2022 to January 2026 underwent two MRI examinations including an RSI protocol. MRI-visible lesions were contoured on T2-weighted MRI; in participants with multiple lesions, the index lesion was selected. Mean ADC and RSIrs-max were measured within MRI-visible lesions. Analyses included all visible lesions, same-vendor and cross-vendor subgroups, participants with uhPC, and 20 participants with scans reconstructed with and without zero-filled interpolation (a setting with different defaults across vendors). Pearson correlation coefficients with 10,000 bootstrap resamples were used to estimate 95% confidence intervals. ResultsSixty-one male participants (median age, 69 years [IQR, 63-74]) were evaluated; 58 of 61 (95%) had MRI-visible lesions, and 26 of 58 (45%) had uhPC. For all MRI-visible lesions, correlations were 0.55 (95% CI: 0.23-0.76) for mean ADC and 0.83 (95% CI: 0.72-0.90) for RSIrs-max. In same-vendor scans, correlations were 0.76 (95% CI: 0.27-0.95) and 0.88 (95% CI: 0.72-0.96); in cross-vendor scans, they were 0.31 (95% CI: -0.07-0.62) and 0.79 (95% CI: 0.65-0.89), respectively. In uhPC, correlations were 0.42 (95% CI: -0.02-0.83) for mean ADC and 0.90 (95% CI: 0.77-0.96) for RSIrs-max. With inconsistent versus consistent interpolation, RSIrs-max correlation increased from 0.73 (95% CI: 0.48-0.89) to 0.89 (95% CI: 0.78-0.96). ConclusionADC showed limited reproducibility, particularly across vendors. RSIrs-max has stronger between-session reproducibility across same-vendor, cross-vendor, uhPC, and interpolation analyses.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
Journal of Magnetic Resonance Imaging
16 papers in training set
Top 0.1%
18.4%
2
Magnetic Resonance Imaging
23 papers in training set
Top 0.1%
15.0%
3
Magnetic Resonance in Medicine
85 papers in training set
Top 0.2%
6.7%
4
NMR in Biomedicine
28 papers in training set
Top 0.1%
5.5%
5
Imaging Neuroscience
282 papers in training set
Top 1%
5.5%
50% of probability mass above
6
PLOS ONE
5266 papers in training set
Top 31%
4.8%
7
Scientific Reports
3612 papers in training set
Top 27%
4.0%
8
NeuroImage: Clinical
144 papers in training set
Top 0.8%
3.4%
9
BMJ Open
601 papers in training set
Top 7%
2.6%
10
Human Brain Mapping
329 papers in training set
Top 2%
2.4%
11
NeuroImage
903 papers in training set
Top 4%
1.9%
12
Clinical and Translational Radiation Oncology
10 papers in training set
Top 0.1%
1.7%
13
European Radiology
15 papers in training set
Top 0.4%
1.5%
14
Nature Communications
5641 papers in training set
Top 49%
1.3%
15
Frontiers in Oncology
103 papers in training set
Top 3%
1.1%
16
Aperture Neuro
20 papers in training set
Top 0.3%
1.1%
17
NeuroImage: Reports
29 papers in training set
Top 0.3%
1.1%
18
Diagnostics
50 papers in training set
Top 2%
1.1%
19
Clinical Cancer Research
64 papers in training set
Top 2%
1.1%
20
International Journal of Radiation Oncology*Biology*Physics
25 papers in training set
Top 0.4%
0.8%
21
Medical Physics
14 papers in training set
Top 0.5%
0.8%
22
npj Digital Medicine
118 papers in training set
Top 3%
0.8%
23
Analytical Biochemistry
26 papers in training set
Top 0.5%
0.8%
24
Placenta
22 papers in training set
Top 0.3%
0.8%
25
Biology Methods and Protocols
61 papers in training set
Top 2%
0.8%
26
BMC Cancer
67 papers in training set
Top 2%
0.6%
27
Brain Structure and Function
93 papers in training set
Top 2%
0.6%
28
eBioMedicine
183 papers in training set
Top 8%
0.6%